Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 11, 2008, Pages 2105-2112

  Koral, Kenneth F ^a   Huberty, John P ^b   Frame, Bill ^c   Matthay, Katherine K ^b   Maris, John M ^d   Regan, Denise ^a   Normolle, Daniel ^c   Yanik, Gregory A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Dosimetry; Iodine 131; Liver disease; MIBG neuroblastoma oncology; Radionuclide therapy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; TRACER;

ADOLESCENT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; DOSIMETRY; DRUG DOSE ESCALATION; DRUG INFUSION; HUMAN; LIVER TOXICITY; NEUROBLASTOMA; PRESCHOOL CHILD; RADIATION ABSORPTION; SCHOOL CHILD; STATISTICAL MODEL; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; ABSORPTION; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LIVER; MALE; MODELS, BIOLOGICAL; NEUROBLASTOMA; RADIATION DOSAGE; RADIOMETRY;

EID: 53649107436     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0873-3     Document Type: Article

References (23)

1. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatrics. Lippincott-Raven: Philadelphia, PA; 1997. p. 761-97.
2. Matthay KK. Neuroblastoma. In: Pochedly C, editor. Neoplastic diseases in childhood. Chur, Switzerland: Harwood; 1994. p. 735-78.
3. KK Matthay JG Villablanca RC Seeger 1999 Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and cis retinoic acid New Engl J Med 341 16 1165 1173
4. R Ladenstein C Lasset O Hartmann 1993 Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age as diagnosis: a report from the European Group for bone marrow transplantation J Clin Oncol 11 2330 2341
5. R Ladenstein T Philip C Lasset 1998 Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry K Clin lin Oncol 16 953 965
6. DM Wieland JL Wu LE Brown 1980 Radiolabeled adrenergic neuron blocking agents: adenomedullary imaging with 131-I-iodobenzylguanidine J Nucl Med 21 349 353
7. AJ McEwan B Shapiro JC Sisson 1985 Radioiodobenzylguanidines for the scintigraphic location and therapy of adrenergic tumors Semin Nucl Med 15 2 132 153
8. RS Hattner JP Huberty BL Engelstad 1984 Localization of m-iodo (131-I) benzylguanidine in neuroblastoma Am J Roentegenol 143 373 374
9. KK Matthay K DeSantes B Hasegawa J Huberty RS Hattner A Ablin 1998 Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma J Clin Oncol 16 229 236
10. Yanik GA, Levine JA, Matthay KK, Sisson JC, Shulkin BL, Shapiro B, et al. 131-I-meta-iodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem cell support for the treatment of neuroblastoma. J Clm Oncol. 2002;20(8).
11. KK Matthay C Panina J Huberty 2001 Correlation of tumor and whole body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with 131I-MIBG J Nucl Med 42 1713 1721
12. Jacobsson L, Mattsson S, Johansson L, Lindberg S, Fjalling M. Biokinetics and dosimetry of 131-I-metaiodobenzylguanidine (MIBG). Proceeding of Fourth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN. Nov. 5-8, 1985. p. 389-98.
13. KK Matthay JC Tan JG Villablanca 2006 Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study J Clin Oncol 24 3 500 506
14. Matthay KK, Quach A, Franc BL, Huberty J, Hawkins RA, Jackson H, et al. 131I-Metaiodobenzylguanidine (131I-MIBG) double infusion with autologous stem cell rescue for neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) phase I study. J Clin Oncol 2008; (in press).
15. BL Shulkin JC Sisson KF Koral 1988 Conjugate view gamma camera method for estimating tumor uptake of iodine -131-metaiodobenzylguanidine J Nucl Med 29 542 548
16. Geigy JR, Diem K, Lentner C. Scientific tables. J. R. Geigy Publishers: Basle; 1970.
17. Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources. Oak Ridge National Laboratory ORNL/TM-8381. 1987.
18. Boeckmann AJ, Beal SL, Sheiner LB. NONMEM users guide. Parts I-VIII. San Francisco CA: UCSF; 2006.
19. KR Zasadny KF Koral FM Swailem 1993 Dead time of an anger camera in dual-energy-window-acquisition mode Med Phys 20 4 1115 1120
20. JC Sisson AM Avram SA Lawson PG Gauger GM Doherty 2006 The so-called stunning of thyroid tissue J Nucl Med 47 9 1406 1412
21. KF Koral J Li Y Dewaraja CL Barrett D Regan KR Zasadny 1999 131I anti-B1 therapy/tracer uptake ratio using a new procedure for fusion of tracer images to computed tomography images Clinical Cancer Research 5 3004 3009
22. 131I -tositumomab therapy of previously-untreated lymphoma patients J Nucl Med 44 3 457 464
23. 131I tositumomab using dual modality SPECT/CT imaging at multiple times of patients with follicular lymphoma J Nucl Med 47 5 156P